February 23, 2009
SRI Fund is Category King for January 2009
by Robert Kropp
Eventide's Gilead Fund is designated top multi-cap growth fund by Wall Street Journal
For the month of January, 2009, The Wall Street
Journal designated the Eventide Gilead Fund (ETGLX) as the
top-performing multi-cap growth fund. Funds are ranked by year-to-date total returns.
During the month of January, the Gilead Fund
showed a 2.9% increase in value, outperforming the S&P 500 Index by a wide margin. Data published
in the Journal indicates that only two other multi-cap growth funds increased in value during the
The Gilead Fund is a multi-cap growth fund that seeks to provide long-term
capital appreciation. It invests in a broad range of equity securities without limitation to market
capitalization, with the majority of its holdings falling into the mid- and small-cap range. As of
February 1, 2009, the Fund has $0.8 million in assets under management.
The advisor for
the Fund is Eventide Asset Management,a
Boston-based investment advisory firm that offers no-load mutual funds for both individual and
institutional investors. The Gilead Fund, launched on July 1, 2008, is Eventide's first mutual
Eventide reviews potential investments in an attempt to ensure that the securities
chosen for the Gilead Fund are of companies that are not inconsistent with core Christian ethical
values. Specifically, Eventide seeks to avoid investing in companies that support abortion,
gambling, pornography, tobacco, alcohol, weaponry, violent video gaming, environmentally
irresponsible actions, or animal cruelty.
Currently, the top three stock positions in
the Fund are AMAG Pharmaceuticals, Bristow Group, and El Paso Corp.
SRI World Group, Inc. All Rights Reserved.